These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1794134)

  • 1. Comparison of urinary transforming growth factor-alpha in women with disseminated breast cancer and healthy control women.
    Stromberg K; Duffy M; Fritsch C; Hudgins WR; Sharp ES; Murphy LD; Lippman ME; Bates SE
    Cancer Detect Prev; 1991; 15(4):277-83. PubMed ID: 1794134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary transforming growth factors in neoplasia: separation of 125I-labeled transforming growth factor-alpha from epidermal growth factor in human urine.
    Stromberg K; Hudgins WR
    Cancer Res; 1986 Nov; 46(11):6004-10. PubMed ID: 3019543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoreactive alpha transforming growth factor activity in effusions from cancer patients as a marker of tumor burden and patient prognosis.
    Arteaga CL; Hanauske AR; Clark GM; Osborne CK; Hazarika P; Pardue RL; Tio F; Von Hoff DD
    Cancer Res; 1988 Sep; 48(17):5023-8. PubMed ID: 3165707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of transforming growth factor alpha and its relationship to the epidermal growth factor and alpha-fetoprotein levels in patients with hepatocellular carcinoma.
    Yeh YC; Tsai JF; Chuang LY; Yeh HW; Tsai JH; Florine DL; Tam JP
    Cancer Res; 1987 Feb; 47(3):896-901. PubMed ID: 2433030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct high-performance liquid chromatography pattern of transforming growth factor activity in urine of cancer patients as compared with that of normal individuals.
    Kimball ES; Bohn WH; Cockley KD; Warren TC; Sherwin SA
    Cancer Res; 1984 Aug; 44(8):3613-9. PubMed ID: 6331653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells.
    Arteaga CL; Tandon AK; Von Hoff DD; Osborne CK
    Cancer Res; 1988 Jul; 48(14):3898-904. PubMed ID: 3164252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor receptors in human breast carcinoma cells: a potential selective target for transforming growth factor alpha-Pseudomonas exotoxin 40 fusion protein.
    Arteaga CL; Hurd SD; Dugger TC; Winnier AR; Robertson JB
    Cancer Res; 1994 Sep; 54(17):4703-9. PubMed ID: 8062268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitogenic growth factors in breast fluid obtained from healthy women: evaluation of biological and extraneous sources of variability.
    Gann P; Chatterton R; Vogelsong K; Dupuis J; Ellman A
    Cancer Epidemiol Biomarkers Prev; 1997 Jun; 6(6):421-8. PubMed ID: 9184775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variant forms of rat epidermal growth factor present in the urine of nude rats bearing human tumors.
    Hudgins WR; Orth DN; Stromberg K
    Cancer Res; 1988 Mar; 48(6):1428-34. PubMed ID: 3257897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor alpha enhances secretion of transforming growth factor beta2 in MCF-7 breast cancer cells.
    Danforth DN; Sgagias MK
    Clin Cancer Res; 1996 May; 2(5):827-35. PubMed ID: 9816237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-alpha and insulin-like growth factor-I, but not epidermal growth factor, elicit autocrine stimulation of mitogenesis in endometrial cancer cell lines.
    Reynolds RK; Hu C; Baker VV
    Gynecol Oncol; 1998 Aug; 70(2):202-9. PubMed ID: 9740691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary TGFs1 in neoplasia: immunoreactive TGF-alpha in the urine of patients with disseminated breast carcinoma.
    Stromberg K; Hudgins WR; Orth DN
    Biochem Biophys Res Commun; 1987 Apr; 144(2):1059-68. PubMed ID: 3472521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of estrogen-induced breast cancer cell proliferation by reduction in autocrine transforming growth factor alpha expression.
    Reddy KB; Yee D; Hilsenbeck SG; Coffey RJ; Osborne CK
    Cell Growth Differ; 1994 Dec; 5(12):1275-82. PubMed ID: 7696176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor alpha, beta 1 and beta 2 in breast cyst fluid.
    Lai LC; Siraj AK; Erbas H; Lennard TW
    Anticancer Res; 1994; 14(6B):2805-9. PubMed ID: 7872722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-molecular-weight transforming growth factor activity in the urine of patients with disseminated cancer.
    Sherwin SA; Twardzik DR; Bohn WH; Cockley KD; Todaro GJ
    Cancer Res; 1983 Jan; 43(1):403-7. PubMed ID: 6600160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth.
    Herman ME; Katzenellenbogen BS
    Cancer Res; 1994 Nov; 54(22):5867-74. PubMed ID: 7954416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A soluble transforming growth factor beta type III receptor suppresses tumorigenicity and metastasis of human breast cancer MDA-MB-231 cells.
    Bandyopadhyay A; Zhu Y; Cibull ML; Bao L; Chen C; Sun L
    Cancer Res; 1999 Oct; 59(19):5041-6. PubMed ID: 10519421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Mr 43,000 epidermal growth factor-related protein purified from the urine of breast cancer patients.
    Eckert K; Granetzny A; Fischer J; Nexø E; Grosse R
    Cancer Res; 1990 Feb; 50(3):642-7. PubMed ID: 2297705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of breast cancer cell line-derived paracrine factors that stimulate osteoclast activity.
    Pederson L; Winding B; Foged NT; Spelsberg TC; Oursler MJ
    Cancer Res; 1999 Nov; 59(22):5849-55. PubMed ID: 10582709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta2-induced growth inhibition in human breast cancer cells.
    Gucev ZS; Oh Y; Kelley KM; Rosenfeld RG
    Cancer Res; 1996 Apr; 56(7):1545-50. PubMed ID: 8603400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.